化疗药物治疗双实体肿瘤后继发急性髓系白血病1例并文献复习
Acute Myeloid Leukemia Secondary to Chemotherapy Drug for Double Solid Tumors: A Case Report and Literature Review
DOI: 10.12677/ACM.2022.12101323, PDF,   
作者: 贺瑾瑶：西安医学院，陕西 西安；陕西省人民医院，陕西 西安；魏绪仓*：陕西省人民医院，陕西 西安
关键词: 实体肿瘤；急性髓性白血病；治疗相关性；Solid Tumor； Acute Myeloid Leukemia； Treatment Relevance
摘要: 治疗相关性髓系肿瘤(t-MNs)是实体肿瘤患者化疗和(或)放疗后继发的急性髓性白血病(AML)。文献报道的t-MNs多以一种实体肿瘤继发为主，而相继患两种实体瘤治疗后的t-MNs患者较为罕见。现报道1例经我院诊治的治疗相关性髓系肿瘤患者的资料。
Abstract: Therapy-related myeloid neoplasms (t-MNs) are acute myeloid leukemia (AML) secondary to chem-otherapy and/or radiotherapy in patients with solid tumors. t-MNs reported in the literature are mainly secondary to one type of solid tumor, while t-MNs patients with two types of solid tumor af-ter treatment are relatively rare. A case of therapy-related myeloid neoplasms diagnosed and treated in our hospital was reported.
文章引用：贺瑾瑶, 魏绪仓. 化疗药物治疗双实体肿瘤后继发急性髓系白血病1例并文献复习[J]. 临床医学进展, 2022, 12(10): 9151-9154. https://doi.org/10.12677/ACM.2022.12101323

参考文献

[1] McNerney, M.E., Godley, L.A. and Le Beau, M.M. (2017) Therapy-Related Myeloid Neoplasms: When Genetics and Environment Collide. Nature Reviews Cancer, 17, 513-527. [Google Scholar] [CrossRef] [PubMed]
[2] Claerhout, H., Lierman, E., Michaux, L., Verhoef, G. and Boeckx, N. (2018) A Monocentric Retrospective Study of 138 Thera-py-Related Myeloid Neoplasms. Annals of Hematology, 97, 2319-2324. [Google Scholar] [CrossRef] [PubMed]
[3] Arber, D.A., Orazi, A., Hasserjian, R., et al. (2016) The 2016 Re-vision to the World Health Organization Classification of Myeloid Neoplasms and Acute Leukemia. Blood, 127, 2391-2405. [Google Scholar] [CrossRef] [PubMed]
[4] 危彤, 袁芃. 实体肿瘤治疗相关性髓系肿瘤研究进展[J]. 中国肿瘤临床, 2022(4): 188-192.
[5] Jung, Y. and Lippard, S.J. (2007) Direct Cellular Responses to Platinum-Induced DNA Damage. Chemical Reviews, 107, 1387-1407. [Google Scholar] [CrossRef] [PubMed]
[6] Murray, D. and Mirzayans, R. (2020) Cellular Responses to Plati-num-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer Therapy. International Journal of Mo-lecular Sciences, 21, 5766. [Google Scholar] [CrossRef] [PubMed]
[7] Mirzayans, R. and Murray, D. (2020) Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease Recurrence. International Journal of Molecular Sciences, 21, 1308. [Google Scholar] [CrossRef] [PubMed]
[8] Hesketh, P.J., Arena, F., Patel, D., et al. (2004) A Randomized Controlled Trial of Darbepoetin Alfa Administered as a Fixed or Weight-Based Dose Using a Front-Loading Schedule in Patients with Anemia Who Have Nonmyeloid Malignancies. Cancer, 100, 859-868. [Google Scholar] [CrossRef] [PubMed]
[9] 李德爱, 王大志, 张书瑜, 柳波. 抗肿瘤药物与化疗患者发生骨髓抑制情况的药物流行病学研究[J]. 中国药学杂志, 2010(24): 1968-1970.
[10] Morton, L.M., Dores, G.M., Schonfeld, S.J., et al. (2019) Association of Chemotherapy for Solid Tumors with Development of Thera-py-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era. JAMA Oncology, 5, 318-325. [Google Scholar] [CrossRef] [PubMed]
[11] Lyman, G.H., Dale, D.C., Wolff, D.A., et al. (2010) Acute My-eloid Leukemia or Myelodysplastic Syndrome in Randomized Controlled Clinical Trials of Cancer Chemotherapy with Granulocyte Colony-Stimulating Factor: A Systematic Review. Journal of Clinical Oncology, 28, 2914-2924. [Google Scholar] [CrossRef] 
[12] 李婵娟, 赵海丰, 赵伟鹏, 李倩, 赵智刚, 王晓芳, 于泳, 王亚非, 张翼鷟. 恶性实体瘤继发骨髓增生异常综合征急性髓系白血病11例分析[J]. 中国肿瘤临床, 2015(7): 373-377.

为你推荐